Literature DB >> 19447626

Prion protein biosynthesis and its emerging role in neurodegeneration.

Oishee Chakrabarti1, Aarthi Ashok, Ramanujan S Hegde.   

Abstract

Various fatal neurodegenerative disorders are caused by altered metabolism of the prion protein (PrP). These diseases are typically transmissible by an unusual 'protein-only' mechanism in which a misfolded isomer, PrP(Sc), confers its aberrant conformation onto normal cellular PrP. An impressive range of studies has investigated nearly every aspect of this fascinating event; yet, our understanding of how PrP(Sc) accumulation might lead to cellular dysfunction and neurodegeneration is trifling. Recent advances in our understanding of normal PrP biosynthesis and degradation might have unexpectedly shed new light on this complex problem. Indeed, our current understanding of normal PrP cell biology, coupled with a growing appreciation of its complex metabolism, is providing new hypotheses for PrP-mediated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447626      PMCID: PMC3132587          DOI: 10.1016/j.tibs.2009.03.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  80 in total

1.  Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein.

Authors:  G Zanusso; R B Petersen; T Jin; Y Jing; R Kanoush; S Ferrari; P Gambetti; N Singh
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

2.  Substrate-specific regulation of the ribosome- translocon junction by N-terminal signal sequences.

Authors:  D T Rutkowski; V R Lingappa; R S Hegde
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.

Authors:  Y Yedidia; L Horonchik; S Tzaban; A Yanai; A Taraboulos
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

4.  Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain.

Authors:  S J Kim; R Rahbar; R S Hegde
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

5.  The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.

Authors:  T Jin; Y Gu; G Zanusso; M Sy; A Kumar; M Cohen; P Gambetti; N Singh
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

7.  The efficiency of protein compartmentalization into the secretory pathway.

Authors:  Corinna G Levine; Devarati Mitra; Ajay Sharma; Carolyn L Smith; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2004-10-20       Impact factor: 4.138

8.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 9.  Prion protein biology.

Authors:  S B Prusiner; M R Scott; S J DeArmond; F E Cohen
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

10.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration.

Authors:  R S Hegde; P Tremblay; D Groth; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

View more
  30 in total

1.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Interactions between the conserved hydrophobic region of the prion protein and dodecylphosphocholine micelles.

Authors:  Simon Sauvé; Daniel Buijs; Geneviève Gingras; Yves Aubin
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

Review 3.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 4.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

5.  Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.

Authors:  Silvia Lisa; Beatriz Domingo; Javier Martínez; Sabine Gilch; Juan F Llopis; Hermann M Schätzl; María Gasset
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

6.  Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein.

Authors:  Neena S Rane; Oishee Chakrabarti; Lionel Feigenbaum; Ramanujan S Hegde
Journal:  J Cell Biol       Date:  2010-02-15       Impact factor: 10.539

7.  Cell type-specific neuroprotective activity of untranslocated prion protein.

Authors:  Elena Restelli; Luana Fioriti; Susanna Mantovani; Simona Airaghi; Gianluigi Forloni; Roberto Chiesa
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant.

Authors:  Maria Korom; Kristine M Wylie; Hong Wang; Katie L Davis; Meher S Sangabathula; Gregory S Delassus; Lynda A Morrison
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

9.  Homodimerization as a molecular switch between low and high efficiency PrP C cell surface delivery and neuroprotective activity.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

10.  Impaired transport of intrinsically disordered proteins through the Sec61 and SecY translocon; implications for prion diseases.

Authors:  Sebastian Jung; Jörg Tatzelt
Journal:  Prion       Date:  2018-03-29       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.